Back to today's picksMarket Cap $67M 52W High $54.29 52W Low $9.00 P/E Ratio — EPS (TTM) — Beta 0.69 Sector Biotechnology Price Target —
PTHS
buyPelthos Therapeutics Inc
Analyst ↑Risk
$20.74
-9.69%
Vol: 0 (NaNx avg)
Why PTHS Is in Focus Today
PTHS is down 9.7% today. Price action and volume signal this is worth watching.
Bull Case
Recent catalysts: Oppenheimer Maintains Outperform on Pelthos Therapeutics, Raises Price Target to $62. Pelthos Therapeutics Inc. (PTHS) Q4 2025 Earnings Call Transcript. HC Wainwright & Co. Reiterates Buy on Pelthos Therapeutics, Maintains $60 Price Target
Bear Case
Watch for reversal signals. High volatility names carry elevated risk. Always size positions according to your risk tolerance.
Recent News
Oppenheimer Maintains Outperform on Pelthos Therapeutics, Raises Price Target to $62
Benzinga · Mar 20, 2026
Pelthos Therapeutics Inc. (PTHS) Q4 2025 Earnings Call Transcript
SeekingAlpha · Mar 19, 2026
HC Wainwright & Co. Reiterates Buy on Pelthos Therapeutics, Maintains $60 Price Target
Benzinga · Mar 19, 2026
Volume Analysis
Today0
30D Avg0
MultipleNaNx avg
Analysis is for informational purposes only. Not financial advice. Always conduct your own due diligence before making investment decisions.